Clinical Trial Update: Safety of PET MPI Using the CRCHUM N-13 Ammonia [Phase 4]

View source ↗

Summary

This update notes a Phase 4 clinical trial evaluating the safety of N-13 ammonia for PET myocardial perfusion imaging, sponsored by Centre hospitalier de l'Univ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• N-13 ammonia (nitrogen-13 ammonia)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: N-13 Ammonia Safety | Phase 4 | Status: RECRUITING